Skip to content

Establishment Labs ESTA Return on equity

Return on equity at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
26.4%-3.0pp
AbbVie logo
AbbVieABBV
89%+32.7pp
Globus Medical logo
Globus MedicalGMED
13.3%+8.7pp
Solventum logo
SolventumSOLV
34.8%+24.1pp
Medtronic logo
MedtronicMDT
9.8%+0.4pp
Novanta logo
NovantaNOVT
5.2%-4.6pp

Other financials

Income statement

See full
Revenue$59.9M+44.7%
Gross profit$42.3M+52.2%
Operating income-$6.5M+61.6%
Net income-$13.4M+35.4%
EPS (diluted)-$0.45+35.7%

Balance sheet

See full
Cash & equivalents$68.1M-1.6%
Total debt$252.7M+12.0%
Total equity$14.8M-61.7%
Total assets$351.0M+5.3%

Cash flow

See full
Operating cash flow-$4.3M+79.2%
CapEx$1.9M+146%
Free cash flow-$6.2M+71.3%

Valuation

See full
Market cap$2.56B+41.4%
Enterprise value$2.75B+38.7%
P/S11.2×+0.5×

Profitability

See full
Gross margin70.1%+3.7pp
Operating margin-12.4%-4.8pp
Net margin-19.1%-7.4pp
FCF margin-18.1%-6.6pp

Returns & leverage

See full
Debt / equity17.1×+11.2×
Current ratio-0.4×

Where this comes from

Calculated from Establishment Labs’s reported figures.

Based on trailing twelve months.

The official record: Establishment Labs’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Establishment Labs's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Establishment Labs's return on equity?
Establishment Labs (ESTA) reported return on equity of -164% in Q1 2026.
How has Establishment Labs's return on equity changed year-over-year?
Establishment Labs's return on equity increased by 12.1% year-over-year, from -186.7% to -164%.
What is the long-term trend for Establishment Labs's return on equity?
Over 3 years (2020 to 2025), Establishment Labs's return on equity has grown at a 26.0% compound annual growth rate (CAGR), from -66.5% to -133.3%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.